FluoroPharma Medical, based in Boston, is a developer of imaging agents for use with positron emission tomography (PET). PET is a nuclear medicine imaging technology able to make visible very subtle events occurring deep within the body, uncovering otherwise hidden disease processes prior to the manifestation of more easily identifiable pathologies.
PET offers physicians and researchers insights into body dynamics that no other imaging options can, but it won’t work without tracer chemicals that can be linked to and highlight the reactions being investigated, and many current tracers are simply inadequate for what is needed. FluoroPharma, founded by Dr. David Elmaleh and led by a team with extensive radiopharmaceutical and medical technology experience, is researching new tracer chemicals to meet these needs.
Although there are millions of PET procedures performed in the U.S. annually, most are used in relation to cancer diagnosis. However, several factors have led to a shift in favor of using PET technology for the diagnosis of cardiac disease, which is a primary field of research for FluoroPharma. The company’s lead products, CardioPET and BFPET, are designed to improve patient diagnosis and management by evaluating various forms of cardiac disease at the cellular and molecular level. Molecular imaging is of significant value to patients with acute and chronic forms of coronary artery disease (CAD), providing benefit in the initial evaluation of patients with suspected but unproven CAD, and in those patients in whom a diagnosis of CAD has been established and information on prognosis or risk is required.
The market for novel cardiac PET tracing agents is expected to grow by at least 14% annually over the next five years, to approximately $900 million. It’s largely a wide-open market, other than one currently marketed branded cardiac PET tracer (which suffers from certain issues). FluoroPharma is focused on capitalizing on this fast growing market.
For more information, see the company website at www.FluoroPharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment